Correction to: Population Pharmacokinetic Evaluation of Amikacin Liposome Inhalation Suspension in Patients with Treatment‑Refractory Nontuberculous Mycobacterial Lung Disease
Crossref DOI link: https://doi.org/10.1007/s13318-021-00687-z
Published Online: 2021-04-19
Published Print: 2021-07
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Rubino, Christopher M.
Onufrak, Nikolas J.
van Ingen, Jakko
Griffith, David E.
Bhavnani, Sujata M.
Yuen, Dayton W.
Mange, Kevin C.
Winthrop, Kevin L.
Text and Data Mining valid from 2021-04-19
Version of Record valid from 2021-04-19
Article History
First Online: 19 April 2021